產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
- 400-999-210024小時(shí)服務(wù)熱線
MDA-MB-231(人乳腺癌細(xì)胞) (STR鑒定正確)
貨號(hào):CL-0150
規(guī)格:1×10?cells/T25培養(yǎng)瓶
價(jià)格: ¥1600
生長(zhǎng)培養(yǎng)基:Leibovitz's L-15+10% FBS+1% P/S
產(chǎn)品概述
名稱 | MDA-MB-231(人乳腺癌細(xì)胞) (STR鑒定正確) |
別稱 | MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA231; MB231; MD Anderson-Metastatic Breast-231 |
種屬 | 人類 |
生長(zhǎng)特性 | 貼壁細(xì)胞 |
細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
凍存條件 | 凍存液:55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮 |
培養(yǎng)方案A(默認(rèn)) |
生長(zhǎng)培養(yǎng)基:
培養(yǎng)條件:
氣相:空氣,100%, 溫度:37℃
|
培養(yǎng)方案B(可選) |
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
|
推薦傳代比例 | 1:2-1:4 |
推薦換液頻率 | 2-3次/周 |
注意事項(xiàng) | 1. 該細(xì)胞推薦使用Leibovitz's L-15培養(yǎng)基進(jìn)行培養(yǎng),Leibovitz's L-15不可以通入二氧化碳,會(huì)產(chǎn)生細(xì)胞毒性; 2. 如您沒(méi)有無(wú)二氧化碳的培養(yǎng)箱,可使用DMEM替代Leibovitz's L-15,使用DMEM培養(yǎng)基時(shí)即可正常通入5%二氧化碳; 3. 配套專用培養(yǎng)基默認(rèn)Leibovitz's L-15配置,如需DMEM配方,請(qǐng)聯(lián)系銷售下單備注更改。 |
背景描述 | MDA-MB-231來(lái)自患有轉(zhuǎn)移乳腺腺癌的51歲女病人的胸水。 在裸鼠和ALS處理的BALB/c小鼠中,它能形成低分化腺癌(III級(jí))。細(xì)胞表達(dá)WNT7B癌基因。 |
年齡(性別) | 女性,51歲 |
組織來(lái)源 | 乳腺腺癌,轉(zhuǎn)移性胸膜滲出液 |
細(xì)胞類型 | 腫瘤細(xì)胞 |
腫瘤類型 | 乳腺癌細(xì)胞 |
生物安全等級(jí) | BSL-1 |
倍增時(shí)間 | ~32-42小時(shí) |
致瘤性 | Yes, in ALS treated BALB/c mice, forms poorly differentiated adenocarcinoma (grade III).Yes, in nude mice, forms poorly differentiated adenocarcinoma (grade III). |
受體表達(dá)情況 | epidermal growth factor (EGF), expressed;transforming growth factor alpha (TGF alpha), expressed |
保藏機(jī)構(gòu) | ATCC; CRL-12532ATCC; HTB-26 ATCC; CRM-HTB-26 BCRC; 60425 BCRJ; 0164 DSMZ; ACC-732 ECACC; 92020424 |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X CSF1PO 12,13 D2S1338 20,21 D3S1358 16 D5S818 12 D7S820 8,9 D8S1179 13 D13S317 13 D16S539 12 D18S51 11,16 D19S433 11,14 D21S11 30,33.2 FGA 22,23 PentaD 11,14 PentaE 11 TH01 7,9.3 TPOX 8,9 vWA 15,18 D6S1043 18 D12S391 17,18 D2S441 14,15 -
STR鑒定圖
參考文獻(xiàn)
-
Intrinsic bioactivity of black phosphorus nanomaterials on mitotic centrosome destabilization through suppression of PLK1 kinase(2021/08/05)
作者:Ximing Shao, Zhihao Ding, Wenhua Zhou
期刊:Nature Nanotechnology
DOI:10.1038/s41565-021-00952-x
影響因子 :38.300
-
Fusobacterium nucleatum-mimicking nanovehicles to overcome chemoresistance for breast cancer treatment by eliminating tumor-colonizing bacteria(2024/02/23)
作者:Linfu Chen, Jingjing Shen, Zheyu Kang
期刊:Chem
DOI:10.1016/j.chempr.2024.01.030
影響因子 :23.500
引用產(chǎn)品:CL-0150
-
EVs-on-a-Bubble: Self-Aggregated Click Bubbles Streamline Isolation and Amplified Profiling of Circulating Extracellular Vesicles(2023/12/15)
作者:Binqi Wei, Yuanhang Xiang, Xiaojie Qin
期刊:ADVANCED FUNCTIONAL MATERIALS
影響因子 :19.000
引用產(chǎn)品:CL-0150
-
An all-in-one tetrazine reagent for cysteine-selective labeling and bioorthogonal activable prodrug construction(2024/04/02)
作者:Xinyu He, Jie Li, Xinxin Liang
期刊:Nature Communications
DOI:10.1038/s41467-024-47188-6
影響因子 :16.600
引用產(chǎn)品:CL-0150
-
Mitochondria-targeted magnetic gold nanoheterostructure for multi-modal imaging guided photothermal and photodynamic therapy of triple-negative breast cancer(2020/07/24)
作者:Bo Li, Qian Zhou, Haiyang Wang
期刊:Chemical Engineering Journal
影響因子 :15.100
引用產(chǎn)品:CL-0150
-
Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer(2023/12/26)
作者:Tianjiao Zhou, Mengmeng Zhang, Danmeng Liu
期刊:BIOMATERIALS
DOI:10.1016/j.biomaterials.2023.122447
影響因子 :14.000
引用產(chǎn)品:CL-0150
-
Exosome-tuned MOF signal amplifier boosting tumor exosome phenotyping with high-affinity nanostars(2023/11/11)
作者:Xiaojie Qin, Binqi Wei, Yuanhang Xiang
期刊:BIOSENSORS & BIOELECTRONICS
DOI:10.1016/j.bios.2023.115828
影響因子 :12.600
引用產(chǎn)品:CL-0150
-
Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis(2021/11/20)
作者:Ruoyue Fan, Jiaqi Wu, Yuyang Liu
期刊:Journal Of Experimental & Clinical Cancer Research
DOI:10.1186/s13046-021-02173-5
影響因子 :11.300
-
Tumor acidification and GSH depletion by bimetallic composite nanoparticles for enhanced chemodynamic therapy of TNBC(2024/03/09)
作者:Wenting Chen, Fangfang Hu, Qian Gao
期刊:JOURNAL OF NANOBIOTECHNOLOGY
DOI:10.1186/s12951-024-02308-8
影響因子 :10.200
引用產(chǎn)品:CL-0150
-
Alkenyl oxindole is a novel PROTAC moiety that recruits the CRL4DCAF11 E3 ubiquitin ligase complex for targeted protein degradation(2024/05/20)
作者:Ying Wang, Tianzi Wei, Man Zhao
期刊:PLOS BIOLOGY
DOI:10.1371/journal.pbio.3002550
影響因子 :9.800
引用產(chǎn)品:CL-0150
-
Phosphorylation of USP27X by GSK3β maintains the stability and oncogenic functions of CBX2(2023/11/29)
作者:Yushu Xing, Jirimu Ba-tu, Chongyang Dong
期刊:Cell Death & Disease
DOI:10.1038/s41419-023-06304-y
影響因子 :9.000
引用產(chǎn)品:CL-0150
-
Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer(2021/04/19)
作者:Xinxing Wang, Bingjian Xue, Yujie Zhang
期刊:Cell Death & Disease
DOI:10.1038/s41419-021-03684-x
影響因子 :9.000
引用產(chǎn)品:CL-0040 CL-0041 CL-0149 CL-0150 CL-0152 CL-0290 CL-0525
-
MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis(2021/04/06)
作者:Fengxia Chen, Qingqing Wang, Xiaoyan Yu
期刊:Cell Death & Disease
DOI:10.1038/s41419-021-03661-4
影響因子 :9.000
引用產(chǎn)品:CL-0005 CL-0041 CL-0114 CL-0150 CL-0290 CL-0525 PM150312B
-
Phenotype-related drug sensitivity analysis of single CTCs for medicine evaluation(2020/08/10)
作者:Haimeng Pei, Mei Yu, Defang Dong
期刊:Chemical Science
影響因子 :8.400
-
A Combined Self-Assembled Drug Delivery for Effective Anti-Breast Cancer Therapy(2021/03/23)
作者:Hairong Wang, Yawen Zhang, Xiangle Zeng
期刊:International Journal of Nanomedicine
影響因子 :8.000
-
Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer(2023/01/05)
作者:Peng Xu, Jia Yao, Zhen Li, Meng Wang
期刊:International Journal of Nanomedicine
影響因子 :8.000
引用產(chǎn)品:CL-0150
-
Oxypalmatin regulates proliferation and apoptosis of breast cancer cells by inhibiting PI3K/AKT signaling and its efficacy against breast cancer organoids(2023/03/10)
作者:Xian Lin, Dong Chen, Xinyu Chu
期刊:PHYTOMEDICINE
DOI:10.1016/j.phymed.2023.154752
影響因子 :7.900
-
A self-assembled RNA-triple helix hydrogel drug delivery system targeting triple-negative breast cancer(2019/11/08)
作者:Lairong Ding, Junwei Li, Changrong Wu
期刊:Journal of Materials Chemistry B
影響因子 :7.571
引用產(chǎn)品:CL-0150
-
Simultaneous Fluorescence Visualization of Epithelial-Mesenchymal Transition and Apoptosis Processes in Tumor Cells for Evaluating the Impact of Epithelial-Mesenchymal Transition on Drug Efficacy(2018/09/18)
作者:Mingming Luan, Jinjie Chang, Wei Pan
期刊:Analytical Chemistry
DOI:10.1021/acs.analchem.8b02494
影響因子 :7.400
-
Identifying SLC2A6 as the novel protective factor in breast cancer by TP53-related genes affecting M1 macrophage infiltration(2024/04/16)
作者:Chao Dai, Yuxin Man, Luhan Zhang
期刊:APOPTOSIS
DOI:10.1007/s10495-024-01964-3
影響因子 :7.200
引用產(chǎn)品:CL-0150
-
Assessment of 2-allyl-4,5-dimethoxyphenol safety and attractiveness to mature males of Bactrocera dorsalis (Hendel)(2021/08/04)
作者:Shuzhen Deng, Xinyang Li, Ziming Wang
期刊:Ecotoxicology And Environmental Safety
DOI:10.1016/j.ecoenv.2021.112567
影響因子 :6.800
-
Small nucleolar RNA SNORA71A promotes epithelial-mesenchymal transition by maintaining ROCK2 mRNA stability in breast cancer(2022/03/30)
作者:Ting Hu, Chong Lu, Yun Xia
期刊:Molecular Oncology
影響因子 :6.600
-
UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway(2021/10/20)
作者:Zinan Lu, Jia Song, Tonghui Sun
期刊:Chinese Medical Journal
DOI:10.1097/CM9.0000000000001708
影響因子 :6.100
-
Angelica sinensis polysaccharide suppresses the Wnt/β-catenin-mediated malignant biological behaviors of breast cancer cells via the miR-3187-3p/PCDH10 axis(2024/05/16)
作者:Yan Cai, Yang Wang, Wenjun Su
期刊:BIOCHEMICAL PHARMACOLOGY
影響因子 :5.800
引用產(chǎn)品:CL-0150
-
MICAL-L2, as an estrogen-responsive gene, is involved in ER-positive breast cancer cell progression and tamoxifen sensitivity via the AKT/mTOR pathway(2024/05/09)
作者:Pushuai Wen, Jing Li, Zihao Wen
期刊:BIOCHEMICAL PHARMACOLOGY
影響因子 :5.800
引用產(chǎn)品:CL-0150
-
Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway(2019/10/07)
作者:Tianqi Li, Yudi Xiong, Qingqing Wang
期刊:Artificial Cells Nanomedicine and Biotechnology
DOI:10.1080/21691401.2019.1670670
影響因子 :5.800
-
Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer(2020/01/05)
作者:Huan Tang, Jinglin Chen, Lin Wang
期刊:International Journal of Pharmaceutics
DOI:10.1016/j.ijpharm.2019.118806
影響因子 :5.800
引用產(chǎn)品:CL-0150
-
CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis(2021/07/19)
作者:Mingzhi Zhu, Yanyan Wang, Fang Wang
期刊:Cancer Cell International
DOI:10.1186/s12935-021-02088-3
影響因子 :5.800
-
A universal strategy of glyconanoparticle preparation using a bifunctional linker for lectin sensing and cell imaging(2022/03/25)
作者:Qiuyue Sha, Jian Fei, Chang Tu
期刊:Microchimica Acta
DOI:10.1007/s00604-022-05220-w
影響因子 :5.700
-
Dysfunction of the ST7-AS1/miR-301b-3p/BTG1 ceRNA network promotes immune escape of triple-negative breast cancer(2023/02/14)
作者:Yong Li, Wenge Xin, Fang Liu
期刊:INTERNATIONAL IMMUNOPHARMACOLOGY
DOI:10.1016/j.intimp.2023.109805
影響因子 :5.600
-
Weighted gene correlation network analysis identifies RSAD2, HERC5, and CCL8 as prognostic candidates for breast cancer(2019/06/21)
作者:Jianing Tang, Qian Yang, Qiuxia Cui
期刊:Journal Of Cellular Physiology
影響因子 :5.600
引用產(chǎn)品:CL-0150
-
A Novel Optical Fiber Terahertz Biosensor Based on Anti-Resonance for The Rapid and Nondestructive Detection of Tumor Cells(2023/10/23)
作者:Zhe He, Yueping Luo, Guorong Huang
期刊:Biosensors-Basel
影響因子 :5.400
引用產(chǎn)品:CL-0150
-
Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis | Molecular and Cellular Biology(2021/09/24)
作者:Yihong Huang, Shuo Zheng, Ying Lin, Liming Kea
期刊:Molecular And Cellular Biology
影響因子 :5.300
引用產(chǎn)品:164210 CL-0041 CL-0150 CL-0152 CL-0290 CL-0525 PB180120 PM150110 PM151010
-
Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis(2023/03/03)
作者:Yihong Huang, Shuo Zheng, Ying Lin
期刊:MOLECULAR AND CELLULAR BIOLOGY
影響因子 :5.300
引用產(chǎn)品:CL-0150
-
The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis(2023/02/27)
作者:Yin Duan, Huiling Chen, Min Ling
期刊:MOLECULAR AND CELLULAR BIOLOGY
影響因子 :5.300
引用產(chǎn)品:CL-0150
-
The curcumin analog EF24 inhibits proliferation and invasion of triple-negative breast cancer cells by targeting the lncRNA HCG11/Sp1 axis | Molecular and Cellular Biology(2021/11/15)
作者:Yin Duan, Huiling Chen, Min Ling
期刊:Molecular And Cellular Biology
影響因子 :5.300
-
Genome-wide analyses reveal the regulatory roles of DNA methylation-regulated alternative promoter transcripts in breast cancer(2024/03/19)
作者:Yingdong Song, Tao Shen, Huihui Sun
期刊:HUMAN GENETICS
DOI:10.1007/s00439-024-02653-6
影響因子 :5.300
引用產(chǎn)品:CL-0150
-
Constructing a novel prognostic model for triple-negative breast cancer based on genes associated with vasculogenic mimicry(2024/05/08)
作者:Yu Ren, Luyi Feng, Zhihua Tan
期刊:Aging-US
影響因子 :5.200
引用產(chǎn)品:CL-0150
-
Mechanistic and Functional Studies on the Microbial Induction of Wolfiporia cocos Liquid Fermentation Products(2024/05/18)
作者:Zhikang Yang, Congbao Su, Zhoujie Xu
期刊:Foods
影響因子 :5.200
引用產(chǎn)品:CL-0150
-
Incarvine C and its analogues inhibit the formation of cell cytoskeleton by targeting Rac1(2024/05/31)
作者:Pengxiang Zhao, Jie Zhang, Weirong Song
期刊:BIOORGANIC CHEMISTRY
DOI:10.1016/j.bioorg.2024.107512
影響因子 :5.100
引用產(chǎn)品:CL-0150
-
Bruceantinol works as a CDK2/4/6 inhibitor to inhibit the growth of breast cancer cells(2024/04/10)
作者:Li Sun, Yumeng Wang, Jia Li
期刊:CHEMICO-BIOLOGICAL INTERACTIONS
影響因子 :5.100
引用產(chǎn)品:CL-0150
-
Guided Isolation of An Uncommon Cembranoid Orthoester, Sarcotortin A, and Three Skeletal Diverse Terpenoids from the Hainan Soft Coral Sarcophyton tortuosum Based on Molecular Networking Strategy(2022/12/23)
作者:Zihui Chen, Dandan Yu, Cong Li
期刊:CHEMISTRY-A EUROPEAN JOURNAL
影響因子 :5.020
引用產(chǎn)品:CL-0150
-
Two-carbon tethered artemisinin–isatin hybrids: design, synthesis, anti-breast cancer potential, and in silico study(2023/10/19)
作者:Ruo Wang, Renhong Huang, Yaofeng Yuan
期刊:Frontiers in Molecular Biosciences
DOI:10.3389/fmolb.2023.1293763
影響因子 :5.000
引用產(chǎn)品:CL-0150
-
Enzymatic rhamnosylation of anticancer drugs by an α-l-rhamnosidase from Alternaria sp. L1 for cancer-targeting and enzyme-activated prodrug therapy(2019/08/08)
作者:Li Xu , Xiaohong Liu , Yinping Li
期刊:Applied Microbiology And Biotechnology
DOI:10.1007/s00253-019-10011-0
影響因子 :5.000
-
Oridonin promotes RSL3-induced ferroptosis in breast cancer cells by regulating the oxidative stress signaling pathway JNK/Nrf2/HO-1(2024/04/27)
作者:Shiying Ye, Xiangyan Hu, Shaowei Sun
期刊:EUROPEAN JOURNAL OF PHARMACOLOGY
DOI:10.1016/j.ejphar.2024.176620
影響因子 :5.000
引用產(chǎn)品:CL-0150
-
Orosomucoid 1 promotes epirubicin resistance in breast cancer by upregulating the expression of matrix metalloproteinases 2 and 9(2021/9/24)
作者:Luo Qiong,?Jun Yin
期刊:Bioengineered
DOI:10.1080/21655979.2021.1987067
影響因子 :4.900
-
Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin(2021/06/02)
作者:Yan Wang, Zhiqiang Cheng, Jing Xu
期刊:Bioengineered
DOI:10.1080/21655979.2021.1924544
影響因子 :4.900
-
Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner(2021/10/27)
作者:Jianjun Wang, Kunxian Yang, Junyu Cao
期刊:Bioengineered
DOI:10.1080/21655979.2021.2000731
影響因子 :4.900
-
Baicalein promotes KDM4E to induce BICD1 and inhibit triple-negative breast cancer progression by blocking PAR1 signaling(2024/04/12)
作者:Yun Dong, Gaojian He, Kun Chen
期刊:MOLECULAR CARCINOGENESIS
DOI:10.1002/mc.23724
影響因子 :4.600
引用產(chǎn)品:CL-0150
-
Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer(2024/04/08)
作者:Yiyang Wang, Yongxiang Li, Yubo Jing
期刊:Scientific Reports
DOI:10.1038/s41598-024-58982-z
影響因子 :4.600
引用產(chǎn)品:CL-0150
-
Discovery of Novel 4-Hydroxyquinazoline Derivatives: In Silico, In Vivo and In Vitro Studies Using Primary PARPi-Resistant Cell Lines(2024/03/21)
作者:Lijie Zhu, Binzhuo Liu, Feng Jin
期刊:MOLECULES
影響因子 :4.600
引用產(chǎn)品:CL-0150
-
Proteolysis Targeting Chimeras (PROTACs) based on celastrol induce multiple protein degradation for triple-negative breast cancer treatment(2023/10/28)
作者:Xuelan Gan, Fan Wang, Jianguo Luo
期刊:EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
DOI:10.1016/j.ejps.2023.106624
影響因子 :4.600
引用產(chǎn)品:CL-0150
-
d-arabinose induces cell cycle arrest by promoting autophagy via p38 MAPK signaling pathway in breast cancer(2024/05/16)
作者:Zhenning Tang, Hanying Song, Shaojie Qin
期刊:Scientific Reports
DOI:10.1038/s41598-024-61309-7
影響因子 :4.600
引用產(chǎn)品:CL-0150
-
4-Amino-2-trifluoromethyl-phenyl retinate inhibits proliferation, invasion, and migration of breast cancer cells by independently regulating CRABP2 and FABP5(2022/10/05)
作者:Jing Ju, Nan Wang, Jiali Wang
期刊:Drug Design Development and Therapy
影響因子 :4.319
引用產(chǎn)品:CL-0150
-
4-Amino-2-trifluoromethyl-phenyl retinate inhibits proliferation, invasion, and migration of breast cancer cells by independently regulating CRABP2 and FABP5(2018/04/27)
作者:Jing Ju, Nan Wang, Jiali Wang
期刊:Drug Design Development and Therapy
影響因子 :4.319
引用產(chǎn)品:CL-0150
-
Possible involvement of TGF?β?SMAD?mediated epithelial?mesenchymal transition in pro?metastatic property of PAX6(2020/06/11)
作者:Meng Jin, Daili Gao, Rongchun Wang
期刊:Oncology Reports
影響因子 :4.200
-
The therapeutic effect and targets of herba Sarcandrae on breast cancer and the construction of a prognostic signature consisting of inflammation-related genes(2024/05/10)
作者:Jie Yuan, Minxia Lin, Shaohua Yang
期刊:Heliyon
DOI:10.1016/j.heliyon.2024.e31137
影響因子 :4.000
引用產(chǎn)品:CL-0150
-
SHCBP1 Promotes the Proliferation of Breast Cancer Cells by Inhibiting CXCL2(2023/10/16)
作者:Xiaoke Yu, Guang Feng, Rui Nian
期刊:Journal of Cancer
影響因子 :3.900
引用產(chǎn)品:CL-0150
-
RAB5A polarizes macrophage and promotes breast cancer(2024/03/01)
作者:Lei Qiao, Chao Dong, Wenlei Jia
期刊:ENDOCRINE-RELATED CANCER
影響因子 :3.900
引用產(chǎn)品:CL-0150
-
Tumor-promoting mechanisms of macrophage-derived extracellular vesicles-enclosed microRNA-660 in breast cancer progression(2022/01/27)
作者:Changchun Li, Ruiqing Li, Xingchi Hu
期刊:Breast Cancer Research And Treatment
DOI:10.1007/s10549-021-06433-y
影響因子 :3.800
引用產(chǎn)品:CL-0150
-
Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer(2021/10/29)
作者:Wenqing Tang, Fangshi Xu, Meng Zhao
期刊:Bmc Cancer
DOI:10.1186/s12885-021-08892-4
影響因子 :3.800
-
Isopimaric acid, an ion channel regulator, regulates calcium and oxidative phosphorylation pathways to inhibit breast cancer proliferation and metastasis(2023/02/06)
作者:Jiacheng Li, Xiaozhen Liu, Lin Chen
期刊:TOXICOLOGY AND APPLIED PHARMACOLOGY
DOI:10.1016/j.taap.2023.116415
影響因子 :3.800
引用產(chǎn)品:CL-0007 CL-0093 CL-0149 CL-0150 CL-0152 CL-0290 CL-0525
-
Pectinose induces cell cycle arrest in luminal A and triple-negative breast cancer cells by promoting autophagy through activation of the p38 MAPK signaling pathway(2024/05/24)
作者:Shilong Yu, Zhaoyi Yue, Qilun Liu
期刊:BMC CANCER
DOI:10.1186/s12885-024-12293-8
影響因子 :3.800
引用產(chǎn)品:CL-0150
-
Identification of potential anti-tumor targets and mechanisms of HuaChanSu injection using network pharmacology and cytological experiments in Breast cancer(2024/05/16)
作者:Zetian Yang, Yifan Wang, Shuicai Huang
期刊:PLoS One
DOI:10.1371/journal.pone.0303650
影響因子 :3.700
引用產(chǎn)品:CL-0150
-
LncRNA AFAP1-AS1 Knockdown Represses Cell Proliferation, Migration, and Induced Apoptosis in Breast Cancer by Downregulating SEPT2 Via Sponging miR-497-5p(2022/10/12)
作者:Bo Cai, Xichao Wang, Qingao Bu
期刊:CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
影響因子 :3.632
引用產(chǎn)品:CL-0150
-
circKLHL24 Blocks Breast Cancer Development by Regulating the miR-1204/ALX4 Network(2022/10/12)
作者:Guangming Yi, Dan Wang, Jianjun Han
期刊:CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
影響因子 :3.632
引用產(chǎn)品:CL-0150
-
Role of glutaminyl-peptide cyclotransferase in breast cancer doxorubicin sensitivity(2024/02/28)
作者:Bin Xu, Liu Yang, Lixian Yang
期刊:CANCER BIOLOGY & THERAPY
DOI:10.1080/15384047.2024.2321767
影響因子 :3.600
引用產(chǎn)品:CL-0150
-
Mutant p53 and ELK1 co-drive FRA-1 Expression to induce metastasis in breast cancer(2023/11/16)
作者:Sike Hu, Manxue Wang, Ailing Ji
期刊:FEBS LETTERS
影響因子 :3.500
引用產(chǎn)品:CL-0150
-
Exosome-Derived MicroRNA-221-3p Desensitizes Breast Cancer Cells to Adriamycin by Regulating PIK3r1-Mediated Glycose Metabolism(2024/03/26)
作者:Xiaolu Hong, Xiaoping Pan
期刊:CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
影響因子 :3.400
引用產(chǎn)品:CL-0150
-
DMC triggers MDA-MB-231 cells apoptosis via inhibiting protective autophagy and PI3K/AKT/mTOR pathway by enhancing ROS level(2024/03/21)
作者:Yu Jiang, Sunjie Xu, Miaomiao Guo
期刊:TOXICOLOGY IN VITRO
影響因子 :3.200
引用產(chǎn)品:CL-0150
-
Inhibitory impact of cinobufagin in triple-negative breast cancer metastasis: involvements of macrophage reprogramming through upregulated MME and inactivated FAK/STAT3 signaling(2024/01/26)
作者:Zhaohui Zhu, Hanlu Wang, Xu Qian
期刊:Clinical Breast Cancer
DOI:10.1016/j.clbc.2024.01.014
影響因子 :3.100
引用產(chǎn)品:CL-0150
-
Silence of α1-Antitrypsin Inhibits Migration and Proliferation of Triple Negative Breast Cancer Cells(2018/09/27)
作者:Zhijing Zhao, Junfeng Ma, Ying Mao
期刊:Medical Science Monitor
影響因子 :3.100
-
Stachydrine represses the proliferation and enhances cell cycle arrest and apoptosis of breast cancer cells via PLA2G2A/DCN axis(2024/01/01)
作者:Zhen Zhai, Tianlong Mu, Lina Zhao
期刊:Chemical Biology & Drug Design
影響因子 :3.000
引用產(chǎn)品:CL-0150
-
Identification of novel topoisomerase II alpha inhibitors by virtual screening, molecular docking, and bioassay(2021/7/21)
作者:Che Yu, Jiabao Hu, Walter Luyten
期刊:Chemical Biology & Drug Design
影響因子 :3.000
引用產(chǎn)品:CL-0150
-
Identification of TFR2 as a novel ferroptosis?related gene that serves an important role in prognosis and progression of triple?negative breast cancer(2023/12/05)
作者:Yan Yang, Jie Du, Yunfei Huang
期刊:Oncology Letters
影響因子 :2.900
引用產(chǎn)品:CL-0150
-
Calcium-sensing Receptor, a Potential Biomarker Revealed by Large-scale Public Databases and Experimental Verification in Metastatic Breast Cancer(2024/05/23)
作者:Wanlin Xie, Huimin Xu, Yangyang Cheng
期刊:TECHNOLOGY IN CANCER RESEARCH & TREATMENT
影響因子 :2.800
引用產(chǎn)品:CL-0150
-
PCMT1 knockdown attenuates malignant properties by globally regulating transcriptome profiles in triple-negative breast cancer cells(2023/11/06)
作者:Aili Saiding, Dilinuer Maimaitiyiming, Minglan Chen
期刊:PeerJ
影響因子 :2.700
引用產(chǎn)品:CL-0150
-
Kuwanon C inhibits proliferation and induction of apoptosis via the intrinsic pathway in MDA-MB231 and T47D breast cancer cells(2024/05/31)
作者:Peng Qian, Gangxiang Yuan, Chao Yang
期刊:STEROIDS
DOI:10.1016/j.steroids.2024.109450
影響因子 :2.700
引用產(chǎn)品:CL-0150
-
Overexpression of HOXD8 inhibits the proliferation, migration and invasion of breast cancer cells by downregulating ILP2 expression(2021/7/15)
作者:Xiaoyun Wen,Yu Chen, Xiansong Fang
期刊:Experimental and Therapeutic Medicine
影響因子 :2.700
-
The Antitumor Potential of Extract of the Oak Bracket Medicinal Mushroom Inonotus baumii in SMMC-7721 Tumor Cells(2019/9/22)
作者:Yue Yang, Pingya He, Ning Li
期刊:Evidence-based Complementary and Alternative Medicine
影響因子 :2.650
-
Zinc finger protein 468 up-regulation of TFAM contributes to the malignant growth and cisplatin resistance of breast cancer cells(2024/03/01)
作者:Zhaoyang Jia, Feng Wang, Gongzhuo Li
期刊:Cell Division
DOI:10.1186/s13008-024-00113-1
影響因子 :2.300
引用產(chǎn)品:CL-0150
-
Preclinical efficacy of CBR-5884 against epithelial ovarian cancer cells by targeting the serine synthesis pathway(2024/05/11)
作者:Kunxiang Gong, Yinger Huang, Yanqin Zheng
期刊:Discover Oncology
DOI:10.1007/s12672-024-01013-0
影響因子 :2.200
引用產(chǎn)品:CL-0150
-
DNAJB4 suppresses breast cancer progression and promotes tumor immunity by regulating the Hippo signaling pathway(2023/08/07)
作者:Yanru Chen, Jingjia Li, Lulan Pu
期刊:Discover Oncology
DOI:10.1007/s12672-023-00762-8
影響因子 :2.200
引用產(chǎn)品:CL-0150
-
Hsa_circ_0069094 positively regulates the expression of oncogenic ZNF217 by competitively targeting miR-758–3p to promote the development of breast cancer(2022/11/08)
作者:Huaqing Ou, Jialing Li, Qinhua Lv, Decai Feng
期刊:Reproductive Biology
DOI:10.1016/j.repbio.2022.100708
影響因子 :2.100
引用產(chǎn)品:CL-0041 CL-0150 CL-0525 PM150110 PM150210 PM151010
-
Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3(2023/04/10)
作者:Xue Hu, Baoliang Guo, Tong Sun
期刊:Open Medicine
影響因子 :2.100
引用產(chǎn)品:164210 164215 CL-0149 CL-0150 CL-0211 CL-0383 CL-0525 PB180120 PB180424 PM150140 PM150312 PM150710 PM151010
-
Lidocaine prevents breast cancer growth by targeting neuronatin to inhibit nerve fibers formation(2021/07/01)
作者:Bingda Li, Hao Xu, Chongwu He
期刊:Journal Of Toxicological Sciences
影響因子 :2.000
-
Docetaxel-resistant triple-negative breast cancer cell-derived exosomal lncRNA LINC00667 reduces the chemosensitivity of breast cancer cells to docetaxel via targeting miR-200b-3p/Bcl-2 axis(2022/10/25)
作者:Jindong Li, Jie Kang, Weiyan Liu
期刊:EUROPEAN JOURNAL OF HISTOCHEMISTRY
影響因子 :1.966
引用產(chǎn)品:CL-0150
-
DNAJB4 identified as a potential breast cancer marker: evidence from bioinformatics analysis and basic experiments(2020/12/01)
作者:Linlong Mo, Jiayou Liu, Ziquan Yang
期刊:Gland Surgery
影響因子 :1.800
-
CircRNA DNA methyltransferase 1 silence inhibits breast cancer development by regulating micoRNA-485-3p/zinc finger E-box binding homeobox 1 axis(2021/01/05)
作者:Chen Xie, Junyu Li, Chen Xu
期刊:Journal Of Obstetrics And Gynaecology Research
影響因子 :1.600
-
Single?cell RNA?seq necroptosis?related genes predict the prognosis of breast cancer and affect the differentiation of CD4+ T cells in tumor immune microenvironment(2024/05/28)
作者:Li Guo, Xiuzhen Ma, Hong Li
期刊:Molecular and Clinical Oncology
影響因子 :1.200
引用產(chǎn)品:CL-0150
-
Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell(2019/08/14)
作者:Mingjiang Yao, Xiaodi Fan, Bo Yuan
期刊:BMC Complementary and Alternative Medicine
影響因子 :0.000
引用產(chǎn)品:CL-0150
FAQs
Q:{{item.question}}
A:
產(chǎn)品資料
識(shí)別碼示意圖